Market news

Intuitive Surgical has delivered a 43.1% gain over the past three years, even as the stock has been weaker more recently. This puts fresh focus on whether the current US$412.18 share price is properly backed by the cash the business can generate. With new headlines around robotic surgery and strong recent revenue figures, the key issue now is how that share price lines up against the value implied by its cash flows. The 43.1% return over three years means anyone looking at Intuitive Surgical...

Visa, Intuitive Surgical and Williams Companies headline today's research, with growth opportunities balanced by margin, valuation and execution risks.

Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

At first glance, Gilead Sciences, Inc. (NASDAQ:GILD) and Intuitive Surgical, Inc. (NASDAQ:ISRG) don’t make for the most obvious comparison. One sells medicines led by a massive HIV franchise, while the other has built its business around robotic surgery. Yet both have given investors a similar reason to pay attention this year, which is that growth […]

After de-emphasizing heart surgery for decades due to limits with its earlier platforms, the surgical robot maker is eyeing the large market in cardiovascular disease treatment.

Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 10 years by 3.99% on an annualized basis producing an average annual return of 17.48%. Currently, Intuitive Surgical has a market capitalization

Intuitive Surgical (ISRG) shares fell 10.4% in the past year, while the S&P 500 returned 16.5%. Much of the market has focused on moderating U.S. procedure growth. The more telling number is 144 trade-ins in fiscal Q2 2026, up from 83 a year earlier. Most came from customers moving to the new da Vinci 5 robot. Those trade-ins matter most if upgrades continue and each surgery also earns more. Is that number a blip, or are customers still trading up.

Players: Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker, Zimmer Biomet. Profile covers competitors, segments, regional shares, trends and opportunities. Minimally Invasive Robotic Surgical System Market Minimally Invasive Robotic Surgical System Market Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Minimally Invasive Robotic Surgical System Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. Minimally Invasive Robotic Surgical System Market to Reach $18.15 Bil

Abbott leads in absolute revenue, but Intuitive Surgical's growth rate tells a different story over the past eight quarters.

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Intuitive Surgical (NASDAQ:ISRG) and its peers.

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

Intuitive Surgical (NasdaqGS:ISRG) received the world's first CE mark for transvaginal gynecologic procedures using its da Vinci SP system. The approval expands the da Vinci SP platform's labeled use in Europe to include transvaginal access for gynecologic surgery. The CE mark positions Intuitive Surgical as an early mover in single port, natural orifice gynecologic procedures in the region. The new CE mark for transvaginal gynecologic use is only one part of the broader Intuitive Surgical...

Intuitive Surgical remains a compelling long-term investment, though current valuation still demands strong execution. See why ISRG stock is a Hold.

In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $377.94, denoting a +2.38% move from the preceding trading day.

ISRG is using AI, software, data and advanced instruments to strengthen da Vinci 5 and stay ahead as robotic surgery competition intensifies.

Intuitive Surgical (NASDAQ:ISRG) executives said the company remains focused on global procedure growth, while acknowledging a recent deceleration in U.S. procedures and policy-related uncertainty affecting hospitals. Speaking at a Wells Fargo conference, Executive Vice President, CFO and Enterpris

Based on the average brokerage recommendation (ABR), Intuitive Surgical (ISRG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $350.16, moving 4.51% from the previous trading session.

Sands Capital, an investment management company, released its second-quarter 2026 investor letter for “Sands Capital Global Growth Fund”. The letter can be downloaded here. Global Growth seeks the best growth businesses worldwide, leveraging a research team that explores both developed and emerging markets for sustainable competitive advantages. In the quarter, global equities rebounded strongly, driven […]

Intuitive Surgical's flywheel isn't selling new surgical robots, its selling parts and services to support the ones it has already sold.

You might regret ignoring these companies at current levels.

Both Intuitive Surgical and Stryker just posted their fifth straight earnings beat, and Wall Street is cheering for both. But a structural difference buried inside their business models quietly separates a compounder from a cyclical recovery story.

The stock has dropped more than 30% this year.

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

Intuitive Surgical has notably underperformed the Health Care Equipment industry over the past year, but analysts are highly optimistic about the stock’s prospects.

Compare SS Innovations vs. Intuitive Surgical in medical robotics—why SS Innovations may offer asymmetric upside, stronger growth, and better returns. Click to read.

In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $372.6, indicating a +1.51% shift from the previous trading day.

Intuitive Surgical (ISRG) has been back in focus after reporting another quarter of double digit revenue and procedure growth, supported by adoption of its da Vinci 5, single port system and Ion lung biopsy platform. Despite the strong quarterly update, Intuitive Surgical’s share price has been under pressure, with the stock down 34.09% on a year to date share price return and down 21.38% on a 1-year total shareholder return. This contrasts with its 16.27% total shareholder return over three...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

While investors fixate on a slowdown in current procedures, hospitals are accelerating their investment in the company's core platform, revealing a crucial, under-appreciated strength.

Healthcare investors often face a difficult decision when choosing between companies with very different paths to growth. Some businesses are emerging from temporary industry slowdowns, while others continue compounding through durable competitive advantages. Danaher Corporation (NYSE:DHR) and Intuitive Surgical (NASDAQ:ISRG) illustrate that contrast perfectly. Danaher (NYSE:DHR) is beginning to benefit from improving life sciences spending […]